349 related articles for article (PubMed ID: 31002796)
1. Human Gain-of-Function MC4R Variants Show Signaling Bias and Protect against Obesity.
Lotta LA; Mokrosiński J; Mendes de Oliveira E; Li C; Sharp SJ; Luan J; Brouwers B; Ayinampudi V; Bowker N; Kerrison N; Kaimakis V; Hoult D; Stewart ID; Wheeler E; Day FR; Perry JRB; Langenberg C; Wareham NJ; Farooqi IS
Cell; 2019 Apr; 177(3):597-607.e9. PubMed ID: 31002796
[TBL] [Abstract][Full Text] [Related]
2. Human MC4R variants affect endocytosis, trafficking and dimerization revealing multiple cellular mechanisms involved in weight regulation.
Brouwers B; de Oliveira EM; Marti-Solano M; Monteiro FBF; Laurin SA; Keogh JM; Henning E; Bounds R; Daly CA; Houston S; Ayinampudi V; Wasiluk N; Clarke D; Plouffe B; Bouvier M; Babu MM; Farooqi IS; Mokrosiński J
Cell Rep; 2021 Mar; 34(12):108862. PubMed ID: 33761344
[TBL] [Abstract][Full Text] [Related]
3. Differential Signaling Profiles of MC4R Mutations with Three Different Ligands.
Paisdzior S; Dimitriou IM; Schöpe PC; Annibale P; Scheerer P; Krude H; Lohse MJ; Biebermann H; Kühnen P
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32059383
[TBL] [Abstract][Full Text] [Related]
4. Brain-derived neurotrophic factor in human subjects with function-altering melanocortin-4 receptor variants.
Hohenadel MG; Thearle MS; Grice BA; Huang H; Dai MH; Tao YX; Hunter LA; Palaguachi GI; Mou Z; Kim RC; Tsang MM; Haack K; Voruganti VS; Cole SA; Butte NF; Comuzzie AG; Muller YL; Baier LJ; Krakoff J; Knowler WC; Yanovski JA; Han JC
Int J Obes (Lond); 2014 Aug; 38(8):1068-74. PubMed ID: 24276017
[TBL] [Abstract][Full Text] [Related]
5. Obesity-associated mutant melanocortin-4 receptors with normal Gα
Gillyard T; Fowler K; Williams SY; Cone RD
J Neuroendocrinol; 2019 Oct; 31(10):e12795. PubMed ID: 31529534
[TBL] [Abstract][Full Text] [Related]
6. The MC4R p.Ile269Asn mutation confers a high risk for type 2 diabetes in the Mexican population via obesity dependent and independent effects.
Vázquez-Moreno M; Locia-Morales D; Valladares-Salgado A; Sharma T; Perez-Herrera A; Gonzalez-Dzib R; Rodríguez-Ruíz F; Wacher-Rodarte N; Cruz M; Meyre D
Sci Rep; 2021 Feb; 11(1):3097. PubMed ID: 33542413
[TBL] [Abstract][Full Text] [Related]
7. A Novel Loss of Function Melanocortin-4-Receptor Mutation (MC4R-F313Sfs*29) in Morbid Obesity.
Trevellin E; Granzotto M; Host C; Grisan F; De Stefani D; Grinzato A; Lefkimmiatis K; Pagano C; Rizzuto R; Vettor R
J Clin Endocrinol Metab; 2021 Mar; 106(3):736-749. PubMed ID: 33247923
[TBL] [Abstract][Full Text] [Related]
8. Signal pathway analysis of selected obesity-associated melanocortin-4 receptor class V mutants.
Sharma S; Thibodeau S; Lytton J
Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165835. PubMed ID: 32423884
[TBL] [Abstract][Full Text] [Related]
9. The Effect Sizes of
Bakhashab S; Filimban N; Altall RM; Nassir R; Qusti SY; Alqahtani MH; Abuzenadah AM; Dallol A
Genes (Basel); 2020 Jan; 11(1):. PubMed ID: 31947684
[TBL] [Abstract][Full Text] [Related]
10. Diverse effect of MC4R risk alleles on obesity-related traits over a lifetime: Evidence from a well-designed cohort study.
Moazzam-Jazi M; Sadat Zahedi A; Akbarzadeh M; Azizi F; Daneshpour MS
Gene; 2022 Jan; 807():145950. PubMed ID: 34481003
[TBL] [Abstract][Full Text] [Related]
11. Regulation of melanocortin-4 receptor signaling: agonist-mediated desensitization and internalization.
Shinyama H; Masuzaki H; Fang H; Flier JS
Endocrinology; 2003 Apr; 144(4):1301-14. PubMed ID: 12639913
[TBL] [Abstract][Full Text] [Related]
12. Identification and functional characterization of three novel human melanocortin-4 receptor gene variants in an obese Chinese population.
Rong R; Tao YX; Cheung BM; Xu A; Cheung GC; Lam KS
Clin Endocrinol (Oxf); 2006 Aug; 65(2):198-205. PubMed ID: 16886960
[TBL] [Abstract][Full Text] [Related]
13. Mouse models for V103I and I251L gain of function variants of the human MC4R display decreased adiposity but are not protected against a hypercaloric diet.
Rojo D; McCarthy C; Raingo J; Rubinstein M
Mol Metab; 2020 Dec; 42():101077. PubMed ID: 32916307
[TBL] [Abstract][Full Text] [Related]
14. Effects of FTO RS9939906 and MC4R RS17782313 on obesity, type 2 diabetes mellitus and blood pressure in patients with hypertension.
Marcadenti A; Fuchs FD; Matte U; Sperb F; Moreira LB; Fuchs SC
Cardiovasc Diabetol; 2013 Jul; 12():103. PubMed ID: 23849767
[TBL] [Abstract][Full Text] [Related]
15. Melanocortin-4 receptor complexity in energy homeostasis,obesity and drug development strategies.
Fatima MT; Ahmed I; Fakhro KA; Akil ASA
Diabetes Obes Metab; 2022 Apr; 24(4):583-598. PubMed ID: 34882941
[TBL] [Abstract][Full Text] [Related]
16. Melanocortin 4 Receptor Gene Sequence Analyses in Diverse Populations.
Edwards MA; Tattoli T; Sureja G; Sykes A; Kaniper S; Gerhard GS
Genet Test Mol Biomarkers; 2019 Dec; 23(12):877-881. PubMed ID: 31742438
[No Abstract] [Full Text] [Related]
17. The role of polygenic susceptibility to obesity among carriers of pathogenic mutations in MC4R in the UK Biobank population.
Chami N; Preuss M; Walker RW; Moscati A; Loos RJF
PLoS Med; 2020 Jul; 17(7):e1003196. PubMed ID: 32692746
[TBL] [Abstract][Full Text] [Related]
18. Constitutive activity in melanocortin-4 receptor: biased signaling of inverse agonists.
Tao YX
Adv Pharmacol; 2014; 70():135-54. PubMed ID: 24931195
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the Impact of Common Polymorphisms of the FTO and MC4R Genes with the Risk of Severe Obesity in Saudi Arabian Population.
Cyrus C; Ismail MH; Chathoth S; Vatte C; Hasen M; Al Ali A
Genet Test Mol Biomarkers; 2018 Mar; 22(3):170-177. PubMed ID: 29466028
[TBL] [Abstract][Full Text] [Related]
20. Long-term weight-loss in gastric bypass patients carrying melanocortin 4 receptor variants.
Moore BS; Mirshahi UL; Yost EA; Stepanchick AN; Bedrin MD; Styer AM; Jackson KK; Still CD; Breitwieser GE; Gerhard GS; Carey DJ; Mirshahi T
PLoS One; 2014; 9(4):e93629. PubMed ID: 24705671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
